Join the Venture Capital Institutional
Co-Investment & Syndication Platform

A dedicated platform for institutional venture capital investors to confidentially execute syndication and co-investments with peers through trusted references, while streamlining startup and LP fundraising and investment activities.

Free to sign up. All users authenticated.

Connect with a trusted network of
institutional VC and LP investors

Streamline investment management,
co-investments, syndication.
Centralize Startup and LP fundraising.
— all in a single, unified platform.

Free to sign up. All users authenticated.

Connecting 5,000+ global VCs
and LPs in one unified platform

Join the exclusive network of VCs, Family Offices, LPs, and Asset Owners to
enable collaborative, direct, and discreet deal-making with verified investors.

Free to sign up. All users authenticated.

CalSTRS promotes Kirsty Jenkinson to Senior Investment Director of Private Markets & SISS, leveraging her expertise in sustainable investing to lead real estate, private equity, and more. #PrivateEquity #SustainableInvesting #CalSTRS

6 days ago|by Team S

GoalVest Venture Capital, a female-founded division of GoalVest Advisory, has announced the first close of GoalVest Venture Growth Fund II, which is targeting a $50 million raise. Approximately 60 Limited Partners (LPs) are participating in this initial close.This fundraising milestone follows the good performance of Fund I, which celebrated the IPO of CoreWeave, a leading AI infrastructure company, in late March 2025. Since its IPO, CoreWeave’s value has increased approximately 2.5 times. Fund I also boasts a net IRR of 40% since its inception in April 2022, significantly outperforming the Forge Private Market Index (FPMI), which declined by about 30% during the same period.GoalVest launched its growth-stage venture platform in response to changing market dynamics in 2020-2021. The firm has reimagined venture capital through several key strategies:Multi-Channel Deal Sourcing: Combining secondary markets with primary funding rounds to access a broader range of companies.Fundamentals First Philosophy: Focusing on fundamental analysis and profitability rather than hype. They view themselves as "stock pickers".Multi-Sector Diversification: Investing across various sectors, including Consumer and Industrials, to mitigate risk.LP-Friendly Structure: Providing shorter fund cycles, faster distributions, lower fees, and more co-investment opportunities.

6 days ago|by Team S

After navigating several years of "tempestuous" conditions, marked by subdued dealmaking, exit activity, and fundraising following an "unsustainable level of exuberance" in 2021, the market is showing clear signs of recovery. A 25% rebound in global private equity and venture capital dealmaking value in 2024 indicates a cautious but growing optimism for steadily improving market conditions in the year ahead and beyond. https://www.newnex.io/blogs/venture-capital/private-markets-set-for-resurgence-in-2025-driven-by-ai-liquidity-and-policy-shifts-global-survey-reveals

7 days ago|by Team S

Though the UK has a broad and diverse innovation base, VC investment is increasingly concentrated in high-growth, early-stage sectors where the UK has an edge. https://privatebank.barclays.com/insights/navigating-the-uk-venture-capital-landscape-08-2025/

8 days ago|by Team S

Continuation vehicles are becoming important in today’s private investment world. They allow investment managers to keep holding onto their best-performing assets longer, instead of being forced to sell them when their original fund reaches its end. If you’re new to the concept or just want a clear overview, here’s everything you need to know - from what they are to how they get set up and why they matter.https://www.newnex.io/blogs/venture-capital/understanding-continuation-vehicles-a-simple-guide-to-structure-setup-and-benefits-for-vcs

8 days ago|by Team S

Time Magazine recently ranked the top US VC firms. At NEWNEX, we’re taking it a step further — building a platform that brings all VCs together to syndicate directly, collaborate on deals, and network without intermediaries.Join www.newnex.io, get verified, and start connecting with fellow investors today.

8 days ago|by Team S

Venture capital (VC) investment in Europe experienced a modest decline in the second quarter of 2025, reflecting growing investor caution amid an uncertain geopolitical and trade environment. According to recent data, total VC funding dropped from $16.3 billion in Q1 2025 to $14.6 billion in Q2 2025. https://www.newnex.io/blogs/venture-capital/venture-capital-investment-in-europe-experiences-modest-slowdown-in-q2-2025

10 days ago|by Team S

Almost every major IPO listing in Q2 hit the public markets below its peak valuation, the data from PitchBook adds. Some examples include: MNTN (at IPO, valuation was down from $2 billion to $1.1 billion), Circle (dropping from $7.7 billion to $5.8 billion), Hinge (valuation at IPO was $6.2 billion, down from the $23 billion high), Chime (going public at $9.1 billion from a $25 billion peak valuation).https://fortune.com/2025/08/14/startup-down-rounds-are-at-a-ten-year-high-according-to-pitchbook-data/

12 days ago|by Team S

Porsche Automobil Holding SE and Deutsche Telekom AG are in discussions to serve as anchor investors for a new €500 million venture capital fund focused on European defense technology companies. The fund will be managed by DTCP, an investment firm that was previously part of Deutsche Telekom. This initiative comes amid rising European military spending, especially following Russia’s invasion of Ukraine, which has sparked increased interest in defense investments. Notably, Porsche SE has shifted its investment policy to include companies focused solely on defense, moving beyond its previous focus on dual-use technologies. Both Porsche and Deutsche Telekom have existing investment ties with DTCP and have previously co-invested in defense-related startups such as Quantum Systems, a German drone maker.

14 days ago|by Team S

Private market funds lag US stocks over short and long term State Street private equity index outpaced by S&P 500 over 3 months and 1, 3, 5 and 10 years for first time since 2000Private market funds, including private equity, private debt, and venture capital, have underperformed US large-cap stocks across all standard time horizons for the first time since 2000. According to the State Street private equity index, private market funds returned 7.08% in 2024, compared to a 25.02% total return for the S&P 500. This underperformance is attributed to a slowdown in private equity dealmaking, higher interest rates impacting deal prices and exits, and reduced benefits from leverage and multiple expansion. While private debt and sector-focused funds (notably financial and energy) performed better within private markets, the overall gap with public equities was one of the largest on record. The article notes that although some top private equity managers and sector specialists can still outperform, broad-based private market investments have recently lagged public benchmarks, challenging investor expectations for higher and less volatile returns from private markets.https://on.ft.com/4mxqoj3

16 days ago|by Team S

The European Bank for Reconstruction and Development (EBRD) has invested €20 million in Spire Capital Partners Fund I, a new independent private equity fund based in Poland. The fund, with €90 million under management, will focus on equity and quasi-equity investments in technology-enabled small and medium-sized enterprises (SMEs) in Poland and across central and eastern Europe. Typical investments will range from €5 to €20 million, targeting companies with established market positions and strong growth potential.This investment aims to bridge the financing gap for profitable companies that need professional support to scale, especially in a market where access to alternative funding remains limited. The EBRD’s involvement has been instrumental in helping Spire Capital Partners reach its target size and supports the development of a more dynamic private equity ecosystem in the region. Since 1991, the EBRD has invested over €16 billion in Poland, underlining its commitment to fostering competitiveness and innovation among local enterprisesread more: https://www.ebrd.com/home/news-and-events/news/2025/ebrd-supports-new-independent-private-equity-fund-in-poland.html#

16 days ago|by Team S

Korea Investment Partners (KIP), one of South Korea’s leading venture capital and private equity firms, has invested $10 million in SpaceX. While relatively small compared to the multi-billion-dollar rounds the company has attracted in recent years, the move signals growing international participation in the space sector’s most valuable private company. KIP’s entry comes as SpaceX is estimated to be valued at around $400 billion, placing it among the most valuable privately held enterprises in the world.https://www.newnex.io/blogs/asset-management/korea-investment-partners-makes-strategic-10-million-entry-into-spacex

16 days ago|by Team S

In the first half of 2025, the U.S. venture capital landscape revealed a stark divide, with just 12 firms securing over 50% of all venture capital raised, according to PitchBook’s analysis. This concentration underscores a growing trend where elite, multi-strategy firms dominate fundraising, while smaller and first-time fund managers face significant hurdles.read more: https://www.newnex.io/blogs/venture-capital/12-elite-vc-firms-hauled-over-50-of-the-entire-funds-raised-in-q1-2025

17 days ago|by Team S

Bain Capital Ventures (BCV) has taken a decisive step to strengthen its presence in Israel by appointing Ron Miasnik as the firm’s first partner dedicated to the Israeli market. At just 26, Miasnik is one of the youngest partners at a global venture capital powerhouse, tasked with spearheading BCV’s strategy, deal flow, and portfolio expansion in one of the world’s most vibrant tech ecosystems.The appointment comes after a year in which BCV invested more than $150 million into Israeli startups, backing companies such as Dream, Grain, and Daylight. These deals add to the firm’s established history in the country, with earlier investments in notable names like Armis and Redis.Miasnik’s career trajectory has been rapid and entrepreneurial. A Princeton University graduate with honours in computer science, he co-founded and sold his first startup, Adora, while still a student. His professional background includes product roles at Microsoft and Houzz, and later serving as CEO of BCV portfolio company Duality Labs.Speaking on his new role, Miasnik said, “Bain Capital Ventures has long believed in the power of the Israeli startup ecosystem, and I’m excited to continue investing in its entrepreneurs for many years to come.”BCV Partner Enrique Salem underscored the strategic value of the move: “We are believers in the Israeli ecosystem and are grateful to have Ron at the helm of our efforts there.”Miasnik will focus on expanding BCV’s local network, identifying high-potential startups, and connecting them with the firm’s global platform. His mandate also reflects a broader industry trend—global venture firms are intensifying their pursuit of Israeli innovation, competing for early access to the country’s most promising founders.

17 days ago|by Team S

The venture capital firm Team8 Capital is in the advanced stages of raising a new fund of $250–300 million, Calcalist has learned. This will be the second fund the firm’s partners have raised since the outbreak of the war in Israel on October 7, 2023, and the third overall since the fund’s inception.

17 days ago|by Team S

Rillet, a New York-based accounting and ERP start-up, has just clinched $70 million in Series B funding—only 10 weeks after its $25 million Series A round. The latest investment was co-led by Andreessen Horowitz and ICONIQ, with Sequoia, Oak HC/FT, and existing backers also participating. Notably, Andreessen Horowitz’s Alex Rampell and ICONIQ’s Seth Pierrepont will join Rillet’s board as part of the deal.Founded in 2021, Rillet provides an AI-powered ERP platform that integrates accounts receivable/payable, investor reporting, banking, invoicing, and multi-currency management—making it a full-service financial backbone for modern businesses. In just a year since emerging from stealth, Rillet has raised over $100 million and seen rapid growth, with ARR doubling since its Series A.CEO Nicolas Klopp shared that the round “came together very quickly,” reflecting surging momentum in both product adoption and market interest. Fresh capital will be used to expand Rillet’s AI capabilities, improve products, and grow its engineering and customer success teams.

21 days ago|by Team S

Tesi, a government-backed investor, manages €3B+ and helps bridge risk gaps in early-stage VC, biotech, and deep tech.Europe’s VC ecosystem is evolving fast, with strengths in deep tech and life sciences—but we still need robust late-stage capital and a true pan-European tech exchange to retain high-growth companies.Fund manager due diligence is getting sharper: alignment, transparency, and “skin in the game” matter more than ever for long-term partnerships.Investment teams need both financial expertise and strong relationship skills to add long-term value.With a shifting macro landscape, it’s time to take a proactive view—focus on quantum, AI hardware, and green energy for sustainable growth.https://ionanalytics.com/insights/mergermarket/enni-rautio-interim-director-of-fund-investment-at-tesi-on-trends-in-fund-investing/

21 days ago|by Team S

Berlin’s artificial intelligence startup n8n has become the latest European tech unicorn, after venture capital firm Accel is said to lead a funding round pushing its valuation to $2.3 billion—up from $350 million just four months earlier. Meritech Capital, among other investors, is expected to join the hundreds-of-millions-euro round, reflecting a booming appetite for AI bets across the continent.Bloomberg reports that Accel overcame competing offers from heavyweights like Insight Partners to claim the lead role in n8n’s latest round. The new funding, which dramatically outpaces previous company valuations reported by outlets such as the Financial Times, is pre-money—meaning it excludes the new capital set to flow in.Founded in 2019, n8n specializes in software that automates business tasks using AI-powered agents, touted as the next evolutionary leap beyond chatbots. The company now surpasses $40 million in annual recurring revenue and counts blue-chip firms like Vodafone Group and Delivery Hero among its major clients. Earlier this year, n8n secured €55 million in a funding round led by Highland Europe and reported a fivefold annual revenue increase.The investment surge tracks a broader trend in European tech. Paris-based Mistral AI is reportedly in advanced talks to raise up to $1 billion. Helsing, headquartered in Germany and focused on AI for drones and defense, doubled its value to €12 billion. Meanwhile, Swedish firm Lovable recently netted $200 million, sealing its status as a unicorn.

21 days ago|by Team S

SoftBank Group has kicked off fiscal 2025 with a dramatic upswing, posting a robust net profit of 421.8 billion yen ($2.87 billion) in the first quarter. This surge underscores a remarkable financial turnaround for the Japanese conglomerate, propelled by a bold investment strategy centered on artificial intelligence.https://www.newnex.io/blogs/asset-management/softbanks-soaring-q1-2025-ai-bets-pay-off-as-profit-surges

21 days ago|by Team S

Index Ventures’ returns: An initial $86.5 million stake turned into nearly $6 billion at IPO, helping Index reap well over $11 billion across exits with other portfolio companies like Scale AI and Wizhttps://www.wsj.com/finance/investing/figma-ipo-index-ventures-6d882d2d

23 days ago|by Team S

Frazier Life Sciences has closed a new $1.3 billion venture fund aimed at early-stage biotechnology investments. The fund will support the creation and development of startups focused on preclinical and early clinical-stage therapies.This move places Frazier among the leading biotech venture firms recently raising large funds, reflecting continued interest in innovation despite challenging market conditions.🔬 Investment Focus and Track RecordFrazier has been one of the most active early-stage investors in life sciences, backing numerous private companies and frequently leading funding rounds. Its portfolio includes companies working in oncology, kidney disease, and targeted immune therapies.Several of its portfolio companies have achieved significant milestones, including acquisitions by major pharmaceutical firms and successful IPOs. These outcomes highlight Frazier’s ability to identify and scale promising biotech ventures.📉 Biotech Market LandscapeThe broader biotech sector is experiencing funding pressures. Venture investment in seed and Series A rounds has declined significantly, reflecting cautious investor behavior. Larger, later-stage funding rounds are becoming more common, while early-stage deals are less frequent.Despite this, Frazier’s successful fundraise shows that there is still strong investor confidence in experienced firms with a track record of generating returns from early-stage biotech innovation.

23 days ago|by Team S

Venture capital firm CRV has raised a $750 million fund—its 20th—to invest exclusively in early-stage startups. This marks a significant strategic shift for the firm, which is moving away from late-stage investing after returning a large portion of capital from a previous follow-on fund. CRV believes that doubling down on seed and Series A investments aligns better with its strengths and offers higher long-term returns.The decision to scale back came after concerns that late-stage investments were underperforming and potentially hurting overall portfolio returns. Rather than pursuing another growth-stage fund, CRV chose to streamline its focus, concentrating solely on the early stages where it has historically had the most success.Despite the smaller fund size compared to previous efforts, demand from limited partners was exceptionally high. The firm raised the full $750 million in just four weeks, with investor interest significantly exceeding the amount offered.CRV plans to target sectors such as consumer technology and developer tools. With a long history of successful early bets, including many IPOs and acquisitions, the firm is positioning itself to capitalize on fresh opportunities in the startup ecosystem by staying lean, disciplined, and committed to its early-stage roots.

23 days ago|by Team S

Companies staying private longer has structurally hurt the publicly traded small caps, and moreover has helped the mega caps, because they can buy the private companies and hoover up those growth engineshttps://www.institutionalinvestor.com/article/dimensional-lead-institutions-are-pushing-breaks-private-markets

23 days ago|by Team S

Anaconda, a leading provider of open-source tools and enterprise-grade solutions for data science and machine learning, has raised $150 million in Series C funding. The funding round was led by Insight Partners, a prominent global venture capital and private equity firm.This latest capital injection marks a significant milestone for Anaconda as it aims to expand its platform capabilities and accelerate the adoption of its Python-based data science solutions across industries. The funding will help the company enhance product development, grow its global team, and invest in community-driven initiatives that support the broader data science ecosystem.With a user base that includes millions of data scientists, engineers, and analysts worldwide, Anaconda has long been recognized for its open-source distribution and tools that simplify package management and deployment of machine learning models. The company’s platform is widely used in enterprise settings for data processing, analytics, and AI workflows.Peter Wang, co-founder and CEO of Anaconda, emphasized the company’s mission to democratize data science and machine learning. “This investment will allow us to scale our efforts in delivering innovative solutions that empower practitioners and enterprises to leverage the full potential of open-source technologies,” Wang said.Insight Partners' investment reflects a growing interest in data science platforms that bridge the gap between open-source development and enterprise-grade infrastructure. The firm noted Anaconda’s strong community presence and market leadership as key factors behind the decision to lead the round.Anaconda plans to use the funding to expand its reach, forge new partnerships, and support initiatives aimed at improving accessibility and security in data science workflows. The company also intends to focus on enhancing its commercial offerings, including secure repositories, governance tools, and scalable deployment options.This Series C round positions Anaconda for continued growth as the demand for data science and AI solutions continues to rise across sectors such as finance, healthcare, retail, and manufacturing.

a month ago|by Team S

San Francisco-based artificial intelligence startup Anthropic is in advanced discussions to raise between $3 billion and $5 billion in a funding round that would value the company at $170 billion, according to sources familiar with the matter. The round, led by Iconiq Capital, underscores the intense investor enthusiasm for AI companies driving innovation in the rapidly expanding generative AI market. This news comes just months after Anthropic secured $3.5 billion at a $61.5 billion valuation in March 2025, highlighting its meteoric rise in valuation and prominence within the AI sector.A Rapidly Rising Star in AIFounded by former OpenAI research executives, including CEO Dario Amodei and President Daniela Amodei, Anthropic has emerged as a formidable competitor to industry leaders like OpenAI, Google, and xAI. The company is known for its AI chatbot, Claude, which rivals OpenAI’s ChatGPT and Google’s Gemini in functionality and enterprise adoption. Claude has gained significant traction among businesses, contributing to Anthropic’s annualized revenue of approximately $3 billion as of mid-2025, a sharp increase from $1 billion in December 2024. The company’s focus on enterprise sales, with clients like Zoom, Snowflake, and Pfizer, has fueled its rapid growth, with many customers spending upwards of $100,000 annually on its AI solutions.Strategic Investments and PartnershipsAnthropic’s growth has been bolstered by substantial backing from tech giants Amazon and Google. Amazon has invested a total of $8 billion in the startup, including a $4 billion infusion in November 2024, making it Anthropic’s largest investor. As part of this partnership, Amazon Web Services became Anthropic’s primary cloud and training partner, with the startup leveraging AWS’s Trainium and Inferentia chips to train and deploy its advanced AI models. Google has committed over $3 billion, including a $1 billion investment in January 2025, and holds a 10% stake in the company alongside a significant cloud contract. These strategic alliances have provided Anthropic with the computational resources and financial support needed to compete in the high-stakes AI arms race.Innovation Driving ValuationAnthropic’s rapid valuation growth reflects its technological advancements and market positioning. In October 2024, the company unveiled its “Computer Use” capability, allowing Claude to interact with computers in a human-like manner by interpreting screens, navigating software, and executing complex tasks autonomously. This feature, which supports tasks with “tens or even hundreds of steps,” has positioned Anthropic as a leader in practical AI applications for businesses. Additionally, the September 2024 launch of Claude Enterprise, tailored for corporate use, and the introduction of the Claude 3.5 Sonnet model have further strengthened Anthropic’s offerings, driving a tenfold increase in revenue from code generation and software development between March and May 2025.Tapping Middle Eastern CapitalTo sustain its rapid growth and stay competitive in the AI race, Anthropic is reportedly exploring investment from Middle Eastern sovereign wealth funds, including discussions with the Qatar Investment Authority and Singapore’s GIC. This marks a shift from the company’s earlier stance, as CEO Dario Amodei had previously expressed concerns about the national security implications of accepting funds from authoritarian regimes, notably refusing Saudi Arabian investment in 2024. However, a memo indicates Amodei’s evolving perspective, noting that securing Gulf sovereign wealth is increasingly necessary to stay on the frontier of AI development. This move aligns with broader industry trends, as competitors like OpenAI are also seeking Middle Eastern capital, with OpenAI partnering with Emirati firm G42 to build a massive data center in Abu Dhabi as part of its $40 billion funding round.The AI Market’s Billion-Dollar RaceAnthropic’s fundraising efforts come amid a surge of investment in the AI sector, which is projected to generate over $1 trillion in revenue within the next decade. The company’s valuation trajectory mirrors that of its rivals, with OpenAI valued at $300 billion and xAI at over $40 billion following their respective funding rounds in 2024. Anthropic’s ability to attract significant capital reflects investor confidence in its potential to capture a substantial share of the generative AI market, particularly in enterprise applications. The company’s $2.5 billion credit facility, secured in May 2025, further enhances its financial flexibility as it scales operations.Despite its success, Anthropic has faced challenges. The company dealt with a lawsuit from Reddit alleging unauthorized use of content, highlighting the ethical and legal complexities of AI development. Additionally, Amodei has been vocal about the societal implications of AI, predicting that it could eliminate up to 50% of entry-level office jobs while advocating for tighter U.S. export controls on AI chips in response to China’s DeepSeek advancements. These debates underscore Anthropic’s role as a thought leader in navigating the geopolitical and ethical dimensions of AI.

a month ago|by Team S

The Teacher Retirement System of Texas (TRS), a $211 billion pension fund, is increasingly concerned about the influx of retail investor capital into private equity and real estate, which is projected to grow from $4 trillion to $13 trillion by 2032, potentially accounting for 22% of global alternative assets. This surge, discussed at a recent TRS investment committee meeting, raises risks around liquidity, transparency, and valuations, as retail investors could swell fund sizes, dilute institutional influence, and impact co-investment opportunities. TRS is researching ways to mitigate these risks, including setting caps on retail capital in funds they invest in and leveraging their long-term investor status to maintain strong manager relationships, while also adjusting their private equity allocation to 12% in line with new strategic goals.https://www.top1000funds.com/2025/07/trs-eyes-threat-of-retail-investors-in-private-markets/

a month ago|by Team S

Major asset managers like EQT, Franklin Lexington, and Oaktree are launching semi-liquid funds aimed at retail investors. These offer lower minimums (as low as £25K) and periodic liquidity windows, making private markets more accessible1. Increased Accessibility: Private markets, including private equity and venture capital, are now more open to retail investors due to regulatory changes and new investment platforms.2. Lower Entry Barriers: Previously, private market investments required substantial capital, limiting access to wealthy individuals. New products like private market funds and crowdfunding platforms have reduced minimum investment requirements.3. Diversification Benefits: Private markets provide diversification, with low correlation to public markets, potentially lowering portfolio risk and boosting returns.4. Technological Advancements: Online marketplaces and fintech apps have streamlined the process of investing in private companies, making it easier for retail investors.5. Potential for High Returns: Private markets can yield higher returns, especially through early-stage investments in startups or growth companies, but with increased risks.6. Regulatory Changes: Updates to accredited investor rules and the expansion of Regulation A+ and Regulation Crowdfunding have broadened access to private markets.7. Risks Remain: Despite greater affordability, private market investments involve significant risks, including illiquidity, long investment horizons, and higher volatility, requiring careful consideration.Investors should conduct thorough due diligence and understand the risks before investing in private markets.https://www.msn.com/en-gb/money/other/profiting-from-the-potential-of-private-markets-has-become-more-affordable/ar-AA1Jnfx9

a month ago|by Team S

The Berlin Commissioner for Data Protection has formally requested Google and Apple to remove the DeepSeek AI application from the application stores due to GDPR violations.The commissioner, Meike Kamp, alleges that DeepSeek’s owner, Hangzhou DeepSeek Artificial Intelligence, based in Beijing, unlawfully collects data from German users and transfers them for processing in servers in China.https://www.bleepingcomputer.com/news/security/germany-asks-google-apple-remove-deepseek-ai-from-app-stores/

2 months ago|by Team S

Vugene, a Lithuanian startup specializing in multi-omics data analysis, has raised €1 million in a seed funding round led by Superhero Capital, with participation from ScaleWolf and angel investors including Darius Žurauskas, Donatas Karčiauskas, and Gytis Labašauskas. The company aims to transform complex biological data into actionable insights for researchers tackling global health challenges such as cancer, neurodegenerative diseases, and rare disorders.Vugene leverages advanced AI and machine learning to streamline the analysis of multi-omics data—encompassing genomics, proteomics, and metabolomics. Its platform empowers academic institutions, biotech firms, and pharmaceutical companies to accelerate drug discovery and develop precision medicine solutions. With a €16 billion addressable market, Vugene addresses a critical bottleneck in life sciences research, where the volume and complexity of biological data often outpace analytical capabilities.“Vugene’s team is unlocking the potential of multi-omics to drive breakthroughs in healthcare,” said Juha Lindfors, Managing Partner at Superhero Capital. “This funding will enable them to scale their platform and expand their impact in a rapidly growing industry.” The capital will support product development, team expansion, and strategic partnerships, with a focus on integrating additional omics layers and enhancing AI-driven predictive models.Vugene’s platform stands out for its ability to integrate disparate data types, offering researchers a unified interface to identify novel biomarkers and therapeutic targets. Early adopters, including European research institutes, have praised its user-friendly design and ability to reduce analysis timelines significantly. The startup’s proprietary algorithms also prioritize data privacy and compliance with global regulatory standards, positioning it as a trusted partner in sensitive biomedical research.The funding comes amid a surge in investment in Lithuania’s startup ecosystem, which saw €295 million in venture capital in 2022, a 16.8-fold increase since 2017. Vilnius has emerged as a hub for deep-tech and biotech innovation, with companies like Biomatter and Nord Security also securing significant funding in recent years. Vugene’s raise underscores the Baltic region’s growing appeal to international investors seeking high-growth opportunities in AI and life sciences.Market analysts view Vugene’s technology as a timely response to the global demand for personalized medicine, projected to grow at a compound annual growth rate (CAGR) of 11.2% through 2030. By enabling faster and more accurate analysis, Vugene could play a pivotal role in reducing the $2.6 billion average cost of bringing a new drug to market. The startup’s focus on neurodegenerative diseases also aligns with urgent global health priorities, as conditions like Alzheimer’s affect over 50 million people worldwide.As Vugene prepares to expand its footprint, the company is eyeing collaborations with U.S. and Asian biotech firms while strengthening its European presence. The successful funding round, backed by Superhero Capital, ScaleWolf, and prominent Lithuanian angel investors, marks a significant milestone for Lithuania’s biotech sector and signals Vugene’s potential to become a global leader in multi-omics research.--Newnex is a trusted, reference-based platform where VCs, LPs, and startup teams connect privately to collaborate on fundraising, co-investing, and building networks. SignUp Free now www.newnex.io

4 months ago|by Team S

Hamilton Lane, a leading global private markets investment firm, has announced the launch of the Hamilton Lane Venture Capital and Growth Fund (HLVCG), a new evergreen investment vehicle registered under the Investment Company Act of 1940. https://www.newnex.io/blogs/venture-capital/hamilton-lane-launches-us-venture-capital-and-growth-evergreen-fund

4 months ago|by Team S

Network
&
Platform

The Global Venture Capital Network

Newnex's venture capital network connects institutional investors - venture capitalists (VCs) and limited partners (LPs) and venture-scale startups. Our platform fosters trusted fundraising and investing collaboration between investors and founders.

A Platform for Co-Investing & Syndication

Newnex streamlines fundraising and investment by providing a centralized platform for managing capital raising, investing, and enables direct connections between institutional investors and startups. VCs and LPs can invite peers to co-invest, syndicate deals, and raise funds - without intermediaries. This efficient approach simplifies and streamlines collaboration.

Confidential & Reference-Driven Deal-Making

Privacy and trust are at the core of Newnex. Our platform enables institutional investors and startups to engage in confidential, reference-based deal-making with full control over their interactions. Digital tools centralize and optimize the investment process, ensuring efficiency and security.

Exclusive, Invite-Only Access

Newnex is a free, invite-only network designed for venture capital investments in the digital era. The platform is open to VCs, family offices, public funds, DFIs, wealth managers, asset managers, and startups - subject to approval to maintain a high-quality, trusted community.

Join Newnex to access a verified network of investors and startups, discover strategic investment opportunities, and collaborate with trusted partners worldwide.